GENETWORx Looking to acquire or partner with Diagnostic Laboratories
King of Prussia, PA, March 17, 2023 (GLOBE NEWSWIRE) — GENETWORx, a private equity backed laboratory, announces it’s looking to buy or partner with other
March 17, 2023
Press & Media Inquiries
GENETWORx In The Press
Learn how GENETWORx Laboratories’ trusted diagnostic services are helping to deliver better health outcomes for patients.
AND THE WINNER IS… GENETWORX LABORATORY DIRECTOR RECEIVES THIS YEAR’S INNSBROOK ROTARY BUSINESS LEADER AWARD
Dr. Matt Beckman, Director of Laboratory Services for GENETWORx, is this year’s winner of the prestigious Innsbrook Rotary Club Business Leader Award. For more than
July 14, 2022
GENETWORx LAUNCHES EDUCATION CAMPAIGN ON HOW GENETIC TESTING CAN HELP DOCTORS PRESCRIBE THE RIGHT MEDICATION
This Week Designated Healthcare Professionals Genomics Education Week by NIH – with June 7 Earmarked to Highlight Pharmacogenomics (PGx) Testing It’s such a simple solution
June 7, 2022
Social Impact Heroes: Why & How Dr Matthew Beckman of GENETWORx Is Helping To Change Our World
Leadership has many aspects, but I think it is best defined as the vision that moves other people in a purposeful direction. Aside from my
May 23, 2022
Money for free COVID-19 testing for all runs out amid federal funding impasse
Money for free COVID-19 testing for all runs out amid federal funding impasse by Justine McDaniel and Erin McCarthy “We just can’t stomach the thought of turning someone
March 23, 2022
As Mental Health Disorders Skyrocket Among Teens and Young Adults, GENETWORx Offers Pharmacogenetic Approach that Improves Ability to Treat Patients with the Right Medication at the Right Dose
Bill Introduced in the U.S. House Seeks Reduction of Adverse Drug Reactions by Raising Awareness and Utilization of Pharmacogenetic Testing GLEN ALLEN, Va., March 2,
March 2, 2022
New COVID-19 testing site opens at State Farm Stadium as hospitals await peak
A new COVID-19 testing site has opened at State Farm Stadium on Monday due to the rise in omicron cases across the Valley. The drive-thru
January 24, 2022
As COVID-19 Testing Takes Center Stage Again, GENETWORx Labs Announces Testing Capacity and Availability to Help Meet Individual and Corporate Testing Demand
– To Assist Employers, Consultants Available to Design Testing Programs to Meet OSHA Deadline; Antigen and PCR Tests Available – For Individuals, GENETWORx has Supplies
December 21, 2021
GENETWORx Launches Aggressive Plan to Buy, Invest, Partner, and License Unique Laboratory Tests
GENETWORx, a national diagnostics laboratory and health management services company, announced today the launch of a program designed to add products, services and capacity to
December 13, 2021
To Meet the New OSHA Shots or Tests Mandate, GENETWORx Offers Custom Testing Programs for Corporations
With Early Investment in Reporting and Compliance Software and Capacity Built During the Pandemic, GENETWORx Provides U.S. Businesses Needed Corporate Testing Expertise American employers of
November 8, 2021
GENETWORx Pooled Testing Program Scaling to 60 Million COVID Tests per Month Enabling K-12 Schools to Re-Open Immediately
After launching highly successful managed testing programs for colleges, GENETWORx leverages testing program expertise and capacity to help K-12 schools Today GENETWORx, a national diagnostic molecular
March 18, 2021
Covid Testing Spurs New Lab Boom
An interview with GENETWORx CEO William Miller was featured in the March 2021 issue of Laboratory Economics. Miller tells Laboratory Economics how investment, the use
March 17, 2021
Henrico-based Genetworx sees massive growth amid pandemic
As the coronavirus pandemic surged early in 2020, Brandywine Living, a New Jersey-based company that operates assisted-living communities in seven states including Virginia, found itself
March 17, 2021
Virginia to pilot COVID-19 testing program in public schools
Virginia is one of a growing number of states exploring testing as a way to combat COVID-19 in K-12 schools. Dr. Laurie Forlano, a deputy
March 17, 2021
As COVID-19 Testing Takes Center Stage Again, GENETWORx Labs Announces Testing Capacity and Availability to Help Meet Individual and Corporate Testing Demand
After launching highly successful managed testing programs for colleges, GENETWORx leverages testing program expertise and capacity to help K-12 schools. Today GENETWORx, a national diagnostic molecular
March 17, 2021
Henrico-based Genetworx sees massive growth during the COVID crisis as a prelude to future business development
As the coronavirus pandemic surged early in 2020, Brandywine Living, a New Jersey-based company that operates assisted-living communities in seven states including Virginia, found itself
March 17, 2021
Be Responsible, Stay Prepared With COVID-19 At-Home Self-Collection Test Kits
If you’re someone who likes to prepare for the days, weeks and months ahead, having a COVID-19 self-collection kit will be immensely helpful as COVID-19
March 17, 2021
Widespread COVID-19 Testing of College Students and Employees Announced by GENETWORx with On-Campus Managed Testing Programs
GENETWORx announced today that it is providing comprehensive mandatory COVID-19 managed testing programs at numerous U.S. colleges this Spring semester. Diagnostic molecular laboratory GENETWORx is conducting on-campus testing programs
March 17, 2021
Bucknell Beats Pandemic Odds, Completes On-campus Academic Year
The University’s partnership with its testing vendor, GENETWORx, ultimately played a big role in medical success. “GENETWORx really stepped up and became our COVID lab,” O’Neil
March 17, 2021
Respiratory Syncytial Virus (RSV) Diagnostic News:
New All-in-One Test for COVID-19/Flu/RSV On January 13th, 2021; TCA/GENETWORx Labs has unveiled a diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection
March 17, 2021
For Media Inquiries
The GENETWORx team is happy to make our industry experts available to assist the news media with their stories.
If you are a member of the press and would like more information, please contact Joe Carmean via email below.